There were 823 press releases posted in the last 24 hours and 156,624 in the last 365 days.

TerraBioGen Receives Funding Award from BC Agri-Innovation Program

/ -- VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/26/16 -- TerraBioGen Technologies Inc., a developer of proprietary high-value agriculturally bioactive products, announces a funding award through the Investment Agriculture Foundation of British Columbia Agri-Innovation Program for floriculture market development.

The award of $37,500 will be applied towards market demonstration and development of TerraBioGen's next generation plant biostimulant products in British Columbia's ornamental plant and floriculture industries.

"We are grateful to BC's Investment Agriculture Foundation for recognizing the value of TerraBioGen's plant biostimulant technology. This project is an expansion of trials conducted last year on poinsettia that showed better establishment, faster crop finish, and improved post-harvest stress tolerance. We will be extending this analysis of performance to other potted plant varieties, cut flowers, foliar crops and bedding plants. The goal is to offer technologies that allow growers to produce a better product at a lower cost," said TerraBioGen's CEO, Blair Heffelfinger.

About TerraBioGen

TerraBioGen Technologies Inc. is a developer of innovative, proprietary, high-value, environmentally sustainable bioproducts and biostimulants that improve crop health and yields, and increase abiotic and biotic stress tolerance in agricultural and horticultural crops. The Company is committed to research and development to continue to improve the effectiveness of its technologies, the quality of its products, and the creation of new product lines. Further, the Company is taking steps to secure intellectual property rights to these bioproducts and to formulate them in order to fully commercialize their potential.

This news release contains certain statements that may be deemed "forward-looking" statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although TerraBioGen believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of TerraBioGen's management on the date the statements are made. Except as required by law, TerraBioGen undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

TerraBioGen Technologies Inc.
Blair Heffelfinger
President & CEO
(604) 444-1023 ext 316

TerraBioGen Technologies Inc.
Bob Nowell
CFO & Corporate Secretary
(604) 444-1023 ext 306